+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

Immunology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2025

  • Report
  • October 2025
  • 500 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
From
From
Interferons Market 2025-2029 - Product Thumbnail Image

Interferons Market 2025-2029

  • Report
  • May 2025
  • 212 Pages
  • Global
From
Darbepoetin Alfa (Aranesp) Market Report 2025 - Product Thumbnail Image

Darbepoetin Alfa (Aranesp) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Central Retinal Vein Occlusion - Pipeline Insight, 2025 - Product Thumbnail Image

Central Retinal Vein Occlusion - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Interferons Market Report 2025 - Product Thumbnail Image

Interferons Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Alopecia - Pipeline Insight, 2025 - Product Thumbnail Image

Alopecia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Excessive Daytime Sleepiness - Pipeline Insight, 2025 - Product Thumbnail Image

Excessive Daytime Sleepiness - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Thrombocytopenia - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Thrombocytopenia - Global Clinical Trials Review, 2025

  • Clinical Trials
  • April 2025
  • 915 Pages
  • Global
From
From
3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

3SBio Inc (1530) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2025
  • 70 Pages
From
Loading Indicator